Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/27/2012US20120244119 Anti-infective agents and uses thereof
09/27/2012US20120244118 Conjugates and compositions for immunotherapy and anti-tumoral treatment
09/27/2012US20120244117 Method of reversing immune suppression of langerhans cells
09/27/2012US20120244116 Method of treatment of philadelphia chromosome positive leukaemia
09/27/2012US20120244115 Treating non-hematopoietic cancer with interleukin 6
09/27/2012US20120244113 Immunogenic composition and methods
09/27/2012US20120244112 Mutant interleukin-2 polypeptides
09/27/2012US20120244111 Pheromones and the Luteinizing Hormone for Inducing Proliferation of Neural Stem Cells and Neurogenesis
09/27/2012US20120244110 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012US20120244088 Organomodified carbosiloxane monomers containing compositions and uses thereof
09/27/2012US20120244077 Methods and compositions for maintenance of a functional wound
09/27/2012US20120241356 Heat- and vibration-stable insulin preparations
09/27/2012CA2831151A1 Aromatic-cationic peptides and uses of same
09/27/2012CA2830792A1 Neuroprotective peptides
09/27/2012CA2830600A1 Compositions and methods for enhancing the pluripotency of stem cells
09/27/2012CA2830325A1 Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
09/27/2012CA2830259A1 Peptides for suppressing inflammation
09/27/2012CA2830069A1 Therapeutic agent for emphysema and copd
09/27/2012CA2829678A1 Method for the production of protein complexes and vaccine compositions comprising the same
09/27/2012CA2829263A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof
09/27/2012CA2828477A1 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
09/27/2012CA2820956A1 Methods and compositions comprising il-7 receptor ligands
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile
09/26/2012EP2502985A1 Method for inducing differentiation of dental pulp cells into odontoblasts
09/26/2012EP2502983A1 Arthrospira-based compositions and uses thereof
09/26/2012EP2502939A1 Nonnatural collagen-like protein and use thereof
09/26/2012EP2502933A2 Method for preparing gintonin, which is a novel glycolipoprotein from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method
09/26/2012EP2502633A1 Recombinant plasmid DNA pMSIN4, encoding a hybrid polypeptide comprising human insulin precursor, E. coli strain BL21 (DE3) / pMSIN4 - producer of recombinant human insulin, the method for the recombinant human insulin production
09/26/2012EP2502632A1 Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis
09/26/2012EP2502631A1 Immune suppressor and its use
09/26/2012EP2502630A2 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
09/26/2012EP2502618A2 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
09/26/2012EP2502076A2 Methods for detecting a mycobacterium tuberculosis infection
09/26/2012EP2502068A2 Urinary triaosylceramide (gb3) as a marker of cardiac disease
09/26/2012EP2501715A1 Template-fixed peptidomimetics with ccr10 antagonistic activty
09/26/2012EP2501712A1 Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2
09/26/2012EP2501411A1 Methods for improving oral delivery
09/26/2012EP2501409A2 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)
09/26/2012EP2501402A1 Suppression of cancer metastasis
09/26/2012EP2501401A1 Method for purifying factor b
09/26/2012EP2501400A1 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
09/26/2012EP2501399A2 Treatment of acute ischemic stroke or intracranial bleeding with tpa and carbamylated erythropoietin
09/26/2012EP2501398A1 Methods and pharmaceutical composition for the treatment of atherosclerosis
09/26/2012EP2501397A2 Methods for producing an immune response to tuberculosis
09/26/2012EP2501396A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE
09/26/2012EP2501395A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections
09/26/2012EP2501390A2 Composition and methods for affecting cytokines and nf-kb
09/26/2012EP2501389A1 Polysaccharide / bmp complexes which are soluble at physiological ph
09/26/2012EP2501367A1 Formulation for hgh and rhigf-1 combination
09/26/2012EP2501362A2 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
09/26/2012EP2501225A1 Pharmaceutical compositions of melanocortin receptor ligands
09/26/2012CN1980696B Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
09/26/2012CN1980694B Use of gelsolin to treat infections
09/26/2012CN1909921B Compositions for reducing bacterial carriage and cns invasion and methods of using same
09/26/2012CN1799625B Preparation of officinal interleukin
09/26/2012CN1788088B Mutant vesicular stomatitis viruses and use thereof
09/26/2012CN1761480B APLIDINE for multiple myeloma treatment
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN1679929B Streptococcal c5a peptidase vaccine
09/26/2012CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1
09/26/2012CN102695954A Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
09/26/2012CN102695723A Improved neurturin molecules
09/26/2012CN102695522A New human rotavirus strains and vaccines
09/26/2012CN102695520A Modulating interstitial pressure and oncolytic viral delivery and distribution
09/26/2012CN102690877A Application of CSNK1A1 gene and expression product thereof
09/26/2012CN102690876A Application of CSNK1G3 gene and expression product thereof
09/26/2012CN102690875A Application of CDK14 gene and expression product thereof
09/26/2012CN102690872A Application of TRIM28 gene and its expression product
09/26/2012CN102690871A Application of TEX14 gene and its expression product
09/26/2012CN102690870A Application of STC2 gene and its expression product
09/26/2012CN102690869A Application of MEP1A gene and its expression product
09/26/2012CN102690868A Application of PDK3 gene and its expression product
09/26/2012CN102690867A Application of NLK gene and its expression product
09/26/2012CN102690866A Application of TRPM7 gene and its expression product
09/26/2012CN102690804A Polyethylene-glycol-modified recombinant homosapiensarginase I, preparation method thereof and application thereof
09/26/2012CN102690354A Recombined dimerization antithrombin III-Fc fusion protein and mammalian cell efficient expression system thereof
09/26/2012CN102690353A Method for rapid screening of modified tumor necrosis factor receptor II-adiponectin globular-site fusion protein and application thereof
09/26/2012CN102690352A Fusion protein containing GLP-1, and pharmaceutical compositions and applications thereof
09/26/2012CN102690346A Polypeptide treating diabetes, its preparation method and application
09/26/2012CN102690344A Use of pedf-derived polypeptides for promoting stem cells proliferation and wound healing
09/26/2012CN102690343A Analgesic active peptide VRD, its preparation method and application
09/26/2012CN102690342A Anti-cancer analgesic peptide VKVR, its preparation method and application
09/26/2012CN102690335A Polypeptide for effectively inhibiting activity of influenza virus polymerase
09/26/2012CN102690332A Novel glycopeptide antibiotic derivative and pharmaceutical composition, and preparation method and purpose thereof
09/26/2012CN102690331A Monosaccharide glycopeptide derivative, pharmaceutical composition, preparation method and purpose thereof and preparation method of intermediate
09/26/2012CN102690330A Tri-substituted glycopeptide derivative and pharmaceutical composition, and preparation method and purpose thereof
09/26/2012CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof
09/26/2012CN102690324A Gynura bicolor protein extract, and preparation method and application thereof
09/26/2012CN102688503A Medical composition for promoting weight gain of fox
09/26/2012CN102688496A CTX (Cyclophosphamide)-mediated targeting nanocarrier and nano medicine carrying system
09/26/2012CN102688494A Preparation method of protein drug-carrying magnetic composite nano-material and application thereof
09/26/2012CN102688483A Composition for treating dermatosis, preparation containing composition and preparation method thereof
09/26/2012CN102688482A Injectable sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688481A Injection for nourishing myocardium
09/26/2012CN102688480A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688479A Composition for preventing xerophthalmia, eye mask with composition and preparation method of eye mask
09/26/2012CN102688478A Injection for treating premature ovarian failure
09/26/2012CN102688477A Medicinal composition for treating respiratory diseases of livestock
09/26/2012CN102688476A Health-care product for repairing liver cells
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 3163